Home › Trials › NCT06315998
Clinical trial No longer in our active list Observational

Using magnetocardiography to diagnose structural heart disease

Official title: Accurate Identification of Structural Heart Disease Using Magnetocardiography as an Innovative and Non-invasive Tool

Run by Qilu Hospital of Shandong University · NCT06315998 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if a new heart imaging method called magnetocardiography can help diagnose heart problems better than traditional tests in people who might have structural heart disease.

Quick facts

Study typeObservational
SexAll
Enrollment2914 (estimated)
SponsorQilu Hospital of Shandong University
Academic / other
Locations1 site (Jinan, Shandong)
Trial IDNCT06315998 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with suspected structural heart disease who are scheduled for echocardiography or cardiac magnetic resonance imaging.

Probably not a fit

Patients with arrhythmias or unstable clinical conditions that prevent them from completing the necessary examinations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of magnetocardiography (MCG) in diagnosing structural heart disease by comparing its results with those obtained from transthoracic echocardiography and cardiac magnetic resonance imaging. Participants will include individuals suspected of having structural heart abnormalities who are scheduled for these standard imaging tests. The study will focus on various conditions such as cardiomyopathy, congenital heart defects, and valvular heart disease. By analyzing the parameters of MCG, the study seeks to improve diagnostic accuracy for these conditions.

Why it matters

Potential benefit: If successful, this study could enhance the diagnostic capabilities for structural heart disease, leading to earlier and more accurate treatment.

How similar studies have gone: While the use of magnetocardiography is a novel approach, similar studies have shown promise in improving diagnostic methods for heart conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Those with suspected structural heart disease who are scheduled to undergo echocardiography or cardiac magnetic resonance. Structural heart disease includes cardiomyopathy (hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, etc.), congenital heart disease (including ventricular septal defect, atrial septal defect, patent ductus arteriosus, Tetralogy of Fallot) syndrome, tricuspid valve malformation, etc.), valvular heart disease (aortic valve stenosis, mitral valve stenosis, etc.), ventricular remodeling caused by myocardial ischemia or cardiac structural changes.
* Signed the consent form.

Exclusion Criteria:

* Those with atrial fibrillation, supraventricular tachycardia, atrioventricular block and other arrhythmias that have not returned to normal;
* Those who are thought to be incapable of completing the relevant examinations by an attending physicians (or physicians with higher qualifications) due to unstable clinical conditions, metal implants, etc., or those who are unable to perform the examinations;
* Those with obvious abnormal thyroid function, severe anemia or other blood diseases and other diseases that obviously affect the circulating blood supply;
* Those with malignant tumors;
* Pregnant or lactating women.

Where it's running

  • China, Shandong Qilu Hospital of Shandong University
    Jinan, Shandong, China     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Qilu Hospital of Shandong University 72
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.